Projects per year
Personal profile
Education
- 2006-2012 Ph.D., Department of Pharmacy, National Taiwan University
- 2005-2006 M.S., Department of Pharmacy, National Taiwan University
- 2000-2005 B.S., Department of Pharmacy, National Taiwan University
Experience
- 2020.08- Associate Professor, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University
- 2016.03-2020.07 Assistant Professor, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University
- 2016.01-2016.03 Postdoctoral Research Fellow, Program for Cancer Molecular Biology and Drug Discovery, Taipei Medical University
- 2013.07-2014.02 Postdoctoral Research Scholar, Academia Sinica
- 2012.02-2013.06 Postdoctoral Research Fellow, National Taiwan University
Awards
- 2019 Young Researcher Award, Taipei Medical University
Research Interests
- 藥理及毒理
- 藥學
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Development of Anti-Bladder Cancer Therapy from Bufadienolides by Targeting Metabolic Reprogramming.
Chen, C.-H. (PI)
8/1/24 → 7/31/25
Project: A - Government Institution › b - National Science and Technology Council
-
天然物對兒童高惡性度神經膠質細胞瘤之治療潛力及其分子作用機轉探討(3/3)
Chen, C.-H. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
蓮子心生物鹼對於兒童神經膠母細胞瘤影響細胞凋亡以及上皮-間質轉化之機轉探討
Chen, C.-H. (PI)
7/1/23 → 2/29/24
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanism of Natural Products in Pediatric High-Grade Gliomas (2/3)
Chen, C.-H. (PI)
8/1/22 → 7/31/23
Project: A - Government Institution › b - National Science and Technology Council
-
Investigating the Therapeutic Potential and Molecular Mechanism of Natural Products in Pediatric High-Grade Gliomas
Chen, C.-H. (PI)
8/1/21 → 7/31/22
Project: A - Government Institution › b - National Science and Technology Council
-
Correction to: The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells (Cell Death & Disease, (2013), 4, 9, (e810), 10.1038/cddis.2013.330)
Chen, M. C., Chen, C. H., Wang, J. C., Tsai, A. C., Liou, J. P., Pan, S. L. & Teng, C. M., Jul 2024, In: Cell Death and Disease. 15, 7, 490.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Targeting CK1δand CK1ϵ as a New Therapeutic Approach for Clear Cell Renal Cell Carcinoma
Lin, Y. C., Sun, D. P., Hsieh, T. H. & Chen, C. H., Dec 1 2024, In: Pharmacology. 109, 6, p. 330-340 11 p.Research output: Contribution to journal › Article › peer-review
-
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer
Tu, C. C., Hsieh, T. H., Chu, C. Y., Lin, Y. C., Lin, B. J. & Chen, C. H., Dec 2024, In: Cell Death and Disease. 15, 12, 908.Research output: Contribution to journal › Article › peer-review
Open Access -
Anti-inflammatory Mechanism of Morin Hydrate by Suppressing the NF-κB/MAPKs Mediated Cell Migration and Modulating Src/FAK and β-Catenin
Jayakumar, T., Sheu, J. R., Yuan, K. C., Yen, T. L., Hsia, C. W., Huang, W. C., Tseng, L. N., Chen, C. H. & Hsia, C. H., Sept 2023, In: Natural Product Communications. 18, 9Research output: Contribution to journal › Article › peer-review
Open Access -
Cucurbitacin E Exerts Anti-Proliferative Activity via Promoting p62-Dependent Apoptosis in Human Non-Small-Cell Lung Cancer A549 Cells
Hsu, H. L., Lin, B. J., Lin, Y. C., Tu, C. C., Nguyen, N. L., Wang, C. C., Chen, M. C. & Chen, C. H., Oct 2023, In: Current Issues in Molecular Biology. 45, 10, p. 8138-8151 14 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Citations (Scopus)